Folivit

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folivit

What is Folivit?

Folivit is a therapeutic supplement containing folic acid, a synthetic form of folate, which is a water-soluble B-vitamin. Folate is an essential nutrient required by the body for various physiological processes, including the synthesis of nucleic acids and the metabolism of amino acids.

Mechanism and Composition

The active ingredient in Folivit, folic acid, serves as a precursor to tetrahydrofolate. This compound is a vital coenzyme in several metabolic reactions. It plays a critical role in DNA synthesis, repair, and methylation, which are fundamental processes for cell division and growth.

Because the human body cannot synthesize folate de novo, it must be obtained through dietary sources or supplementation. Folivit provides a stable, concentrated form of this nutrient to ensure adequate levels are maintained when dietary intake is insufficient or when physiological demands increase.

Role in the Body

Folic acid is particularly important for tissues that undergo rapid cell turnover. Its primary functions include:

  • Red Blood Cell Production: It facilitates the maturation of red blood cells in the bone marrow.
  • Cellular Development: It supports the healthy development of cells and tissues throughout the body.
  • Neurological Support: It contributes to the maintenance of healthy nervous system function.

By supporting these biological pathways, Folivit helps maintain the nutritional requirements necessary for the body's fundamental growth and maintenance processes.

What side effects are possible with Folivit?

Possible Side Effects and Safety Information

Folic acid (Folivit) is generally well-tolerated. The primary adverse reactions documented in regulatory sources relate to the potential for allergic sensitization, which may follow either oral or parenteral administration.

Serious Adverse Reactions and Contraindications

  • Hypersensitivity: Rare instances of severe allergic responses, including anaphylaxis (with symptoms such as shock, difficulty breathing, or severe swelling), have been reported.
  • Contraindication: Folic acid is contraindicated in individuals with a known hypersensitivity to the drug or its components.
  • Vitamin B12 Deficiency Risk: A critical safety concern is the use of high daily doses (typically over 0.1 mg or 1 mg in some labeling) in patients with undiagnosed megaloblastic anemia. Folic acid in these doses can produce a hematological remission (normalizing blood test results) while allowing the underlying Vitamin B12 deficiency—and its associated progressive neurological damage—to worsen or remain unaddressed. Folic acid alone is therefore considered improper therapy for pernicious anemia or other megaloblastic anemias where Vitamin B12 is deficient.

Other Adverse Reactions (Rare/Frequency Not Defined)

Side effects reported less commonly or at higher doses (e.g., 15 mg daily) include mild gastrointestinal upset (such as nausea, abdominal distension, and flatulence), skin reactions (rash, itching), altered sleep patterns, difficulty concentrating, and irritability. The injection formulation may contain a preservative, such as benzyl alcohol, which is associated with serious adverse effects in neonates.


Safety Monitoring

The most important safety consideration is ruling out a Vitamin B12 deficiency before treatment begins or whenever a megaloblastic anemia is suspected. Blood tests for Vitamin B12 and folate levels are standard components of safety monitoring during prolonged therapy to prevent the masking of pernicious anemia.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation on Folic Acid (Folivit) overdose is based on reported symptoms associated with prolonged, high-dose ingestion.

Documented Manifestations and Emergency Action

Overdose manifestations, typically associated with chronic intake of excessive doses (e.g., 15 mg daily), include gastrointestinal effects such as nausea, vomiting, diarrhea, stomach pain, and flatulence. Central Nervous System (CNS) disturbances like altered sleep patterns, difficulty in concentrating, confusion, and irritability have also been reported. Rare instances of severe outcomes, including allergic sensitization and symptoms suggesting anaphylaxis, are documented.

Individuals are required to seek medical attention immediately at the first sign of any overdose symptoms or to consult a doctor or a Poison Control Center right away if more than the recommended dosage is taken.

Supportive Management and Regulatory Precaution

Classification Official Regulatory Statement
Antidote Information Regulatory labeling states no specific antidote is known. Management is defined as symptomatic and supportive treatment
Critical Constraint High daily doses (above 0.1 mg) may obscure pernicious anemia by improving blood cell parameters while allowing progressive neurological damage to continue

The drug's official overdose profile mandates immediate medical evaluation due to the risk of severe hypersensitivity reactions and the crucial necessity of monitoring against the potential for high doses to mask underlying neurological progression of Vitamin B12 deficiency.

Therapeutic Uses of Folivit

What Folivit Treats: Main Uses and Benefits

Folic acid (Vitamin B9) is commonly used to help with conditions presenting with systemic or localized discomfort and is relevant for easing symptoms related to systemic imbalance, such as those associated with deficiency. This essential B vitamin plays a role in managing symptoms related to systemic imbalance. A deficiency in folic acid may cause symptoms related to physical discomfort, symptoms that interfere with daily functioning, and can lead to conditions marked by increased physiological stress, notably megaloblastic anemia.

“The compound supports the patient during difficult episodes by easing distress,” which assists with maintaining functional stability.

Therefore, supplementation assists in managing these symptom clusters that may become intense or disruptive. The compound is applied in addressing conditions associated with acute or disruptive episodes, such as megaloblastic anemia. Furthermore, in situations where patients experience heightened physiological activity (e.g., during early pregnancy), it is used to help reduce the risk of certain serious birth defects (specifically, neural tube defects). This provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Population Eligibility for Folivit (Folic Acid)

The official regulatory labeling for Folivit, which contains Folic Acid, strictly defines the eligible and non-eligible patient populations.


Category Official Regulatory Status
Contraindications (Must Not Use) Untreated Pernicious Anemia or undiagnosed megaloblastic anemia (to prevent masking Vitamin B12 deficiency's neurological damage). Known Hypersensitivity to folic acid or any excipients.
Age-Related Eligibility Use is established in the Adult and Pediatric populations for deficiency treatment. Older adults require caution to ensure Vitamin B12 deficiency is ruled out.
Pregnancy and Lactation Use is permitted and recommended for pregnant women to reduce the risk of Neural Tube Defects. Use is permitted during Lactation.
Conditional Use Patients with Severe Renal Impairment or those with folate-dependent tumors may require special medical consideration and monitoring before use.

Eligibility-Related Restrictions

Eligibility is primarily restricted by the presence of an underlying, uninvestigated Vitamin B12 deficiency, as Folic Acid can correct the anemia associated with this deficiency while the serious nerve damage progresses. Eligible populations include those with confirmed Folic Acid deficiency, women planning conception, and those with increased physiological needs such as patients undergoing haemodialysis or with chronic haemolytic states.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Folivit (Folic Acid) interaction information details conflicts with certain medicines and substances, primarily due to effects on drug concentration or pharmacodynamic antagonism.


Drug-Drug Interaction Patterns

Co-administration with specific anticonvulsants such as Phenytoin is documented to result in a two-way interaction. Folic Acid officially antagonizes the anticonvulsant action of Phenytoin. Conversely, long-term use of anticonvulsants like Phenytoin, Primidone, and Barbiturates can deplete serum and red blood cell folate concentrations.

The regulatory profile also highlights a risk of pharmacodynamic antagonism with folate antagonists. Co-administration with Methotrexate and Pyrimethamine may lead to a decreased response to those medicines. Furthermore, Sulfasalazine is documented to potentially decrease the blood levels and effects of Folic Acid.


Non-Medicinal Substance and Timing Restrictions

Official regulatory documents establish mandatory restrictions for certain combinations. Folic Acid is considered improper therapy in patients with undiagnosed megaloblastic anemia stemming from a Vitamin B12 deficiency at doses greater than 0.1 mg/ day. This restriction is in place to avoid masking the deficiency.

For substances that interfere with absorption, a specific timing separation is required: Antacids containing aluminium or magnesium must not be taken within two hours before or after Folic Acid. The profile also notes that Alcohol consumption may interfere with folate metabolism, and Folic Acid itself may reduce the efficacy of Zinc supplements.

Mechanism of Action

How Folivit Works

Folivit, acting as a precursor to tetrahydrofolate (THF), functions primarily through its involvement in one-carbon unit metabolism. The active folate derivatives serve as essential carriers and donors of one-carbon groups (e.g., methyl groups) for key enzymatic reactions. This cofactor role is crucial for the de novo synthesis of purine bases and the pyrimidine base thymidylate, which are the fundamental molecular components required for DNA and RNA formation.

A distinct pathway involves the active metabolite, 5-methyltetrahydrofolate (5-MTHF). This compound specifically acts as the methyl donor for the enzyme methionine synthase, facilitating the catalytic conversion of homocysteine to methionine. This enzymatic reaction is a vital intersection of folate and homocysteine metabolism. The resulting influence on the concentration equilibrium of homocysteine affects subsequent metabolic cycles that interface with the nervous and vascular systems, demonstrating a core system-level physiological modulation.

Dosage and Administration Information

The administration of Folivit (Folic Acid) is defined by guidelines concerning its route, standardized dosing, and timing. The oral route is the most common method of administration; however, the medicine is also approved for parenteral use (intravenous, intramuscular, or subcutaneous) when oral absorption is compromised.

Standard therapeutic dosing for treating folic acid deficiency varies by region. In many European schedules, the typical regimen for adults and children over one year is 5 mg once daily for a course of up to four months. Conversely, US guidance specifies doses up to 1 mg daily for deficiency treatment. For high-risk prophylaxis against neural tube defects, a 5 mg daily dose is administered, commencing ideally pre-conception and continuing through the first trimester of pregnancy.

The oral tablet should be swallowed whole with water and may be taken with or without food. An important administration constraint is the timing with other agents: Antacids must be administered at least two hours after taking Folic Acid tablets to prevent reduced absorption. Regarding a missed dose, the established protocol is to skip the forgotten dose entirely and return to the normal schedule; instructions prohibit taking a double dose. Specific rules apply to infants, who receive a weight-based dose of 500 micrograms per kg daily for deficiency.

Recent Clinical Evidence

Folivit (Folic Acid): Recent Clinical Evidence

Folivit, which contains the synthetic form of Vitamin B9 known as folic acid, has been the subject of decades of clinical research, primarily focusing on its role in cell division and blood cell formation. Regulatory bodies acknowledge its established use in addressing deficiencies.


Core Deficiency Studies

Clinical trials and established medical literature consistently indicate the use of folic acid in the management of megaloblastic anemia that is specifically due to folate deficiency. Administration has been observed to support the production of red blood cells, white blood cells, and platelets in affected individuals. However, the presence of an underlying Vitamin B12 deficiency must be assessed, as using folic acid alone in these cases may not prevent the progression of neurological symptoms.


Neural Tube Defects (NTD) Prevention

A significant body of evidence, including randomized controlled trials (RCTs) conducted before widespread food fortification, suggested that periconceptional folic acid supplementation was associated with a substantial reduction in the incidence of NTDs, such as spina bifida and anencephaly, in newborns. Subsequent studies, carried out in populations with fortified food sources, have shown more mixed or less pronounced associations. The US Preventive Services Task Force (USPSTF) recommends folic acid supplementation for women who are planning or are capable of pregnancy to help mitigate the potential risk of NTDs.


Emerging Research Areas

Recent research has explored the potential association between folic acid and other health outcomes, including cardiovascular health. Some observational data and meta-analyses suggest that supplementation may be related to lower levels of homocysteine, a biomarker associated with an increased cardiovascular risk. However, the clinical effectiveness of folic acid in improving major cardiovascular endpoints remains an area of active investigation, with results showing some inconsistency regarding direct benefits on measures like flow-mediated dilation (FMD) in adults.

Frequently Asked Questions (FAQ)

Common questions about Folivit (FAQ)

Q: What types of food should be avoided while taking Folivit?

Official regulatory information specifies a mandatory restriction regarding antacids that contain aluminium or magnesium. These must not be taken within two hours before or after Folivit, as they can reduce its absorption. Additionally, the consumption of alcohol is noted to potentially interfere with the body's folate metabolism.

Q: Can Folivit be used by people with a history of heart conditions?

Studies and official information indicate that Folivit has been investigated for its relationship with cardiovascular health, particularly for its potential to help reduce homocysteine levels. However, common heart conditions are not explicitly listed as a contraindication or restriction for use in the main regulatory eligibility documents.

Q: How quickly does Folivit usually start to show an effect?

For patients being treated for deficiency, official product information describes the physiological onset of action. Regulatory documents describe that the bone marrow may show evidence of producing normal blood cell precursors (normoblastic) as early as the first 48 hours of treatment. Evidence of new blood cell production (reticulocytes) may appear within two to five days.

Q: What are the most commonly mentioned side effects of Folivit in patient forums?

Official regulatory adverse event listings, compiled from surveillance, include effects such as mild gastrointestinal upset, skin reactions like a rash, and central nervous system effects such as altered sleep patterns or difficulty concentrating, particularly when higher daily amounts are used.

Q: Can Folivit be taken with common pain relievers like ibuprofen?

Regulatory documents do not list a general interaction warning between Folivit and non-prescription pain relievers like ibuprofen. However, the official profile does highlight specific conflicts with other prescription medicines, such as certain folate-antagonist drugs like methotrexate.

Q: Is Folivit the same as other medicines that treat similar conditions?

Folivit (Folic Acid) is not the same as Vitamin B12, although they are often discussed together. Regulatory documents contain a critical safety statement that Folivit, when used alone in the presence of an untreated Vitamin B12 deficiency, has the potential to correct blood test results while the associated neurological damage progresses.

Q: Are there any long-term health concerns associated with using Folivit?

Authoritative literature notes that the key safety concern related to long-term use is the possibility that Folivit, particularly at higher doses, could mask the hematological signs of an underlying Vitamin B12 deficiency, if that condition is not being concurrently treated.

Q: Is it true that Folivit can make you feel dizzy?

Dizziness is not explicitly listed in the official adverse reactions documentation. However, regulatory documents do report other central nervous system effects—such as confusion, excitement, or impaired judgment—that have been associated with the use of higher daily amounts.

Q: What is Folivit's classification according to the FDA?

According to official sources, the active ingredient in Folivit, Folic Acid, is classified as an essential, water-soluble B-Vitamin (Vitamin B9). It is also categorized as a hematopoietic agent, meaning it plays a key role in the formation of blood cells.

Q: Can people who are allergic to certain dyes still use Folivit?

The official contraindications for Folivit state that it must not be used by individuals with a known hypersensitivity to the active ingredient or any of the inactive ingredients contained in the drug product. Inactive ingredients include components like dyes or preservatives.

Q: How does Folivit interact with coffee or caffeine?

Official regulatory documents do not list caffeine as a specific drug interaction. However, research has been conducted on this relationship, with some evidence suggesting that heavy consumption of caffeine may influence the body's serum folate concentrations.

Q: Does Folivit affect blood pressure levels?

Studies have examined the effects of Folivit supplementation on blood pressure. Some clinical trial data indicates that it may be associated with a reduction in both systolic and diastolic blood pressure in some individuals, which is often linked to its effect on homocysteine levels.

Q: Does Folivit require a special diet or exercise plan?

The regulatory administration instructions for Folivit state that the tablet may be taken with or without food. Official documents do not specify a mandatory special diet or exercise plan that must be followed for the medicine to achieve its intended effect.

Q: Are there studies comparing Folivit to a placebo?

Yes, official summaries of clinical research confirm that a large body of evidence supports the use of Folic Acid. This evidence includes Randomized Controlled Trials (RCTs), which are often structured to compare the effects of Folic Acid against a placebo or a control group.

Q: Are there any known issues with taking Folivit before surgery?

Authoritative sources note a general caution regarding the use of dietary supplements, including Folivit, before a surgical procedure. It is described that physicians may be informed of all supplements being used.

Q: Does Folivit cause weight changes?

Weight change is not listed as a typical side effect in official regulatory documents. However, scientific research has explored the relationship between Folivit and metabolic function, with some animal studies suggesting an association between high levels of folic acid and increased weight gain when combined with a high-fat diet.

Q: Is it okay to take Folivit at night instead of in the morning?

Regulatory instructions for Folivit do not specify a time of day for administration. The focus is on consistency, noting only that the tablet should be swallowed whole with water and can be taken with or without food.

Q: What does the latest research say about Folivit's safety profile?

Recent scientific discussions about Folivit’s safety profile have primarily focused on the potential long-term consequences of high intake in populations where food is already fortified with folic acid. The key regulatory safety consideration continues to be the potential risk of masking Vitamin B12 deficiency.

Q: Is there a risk of dependency or addiction with Folivit?

No. Folivit is an essential water-soluble B-Vitamin used to correct nutritional deficiencies. Official regulatory documents do not contain any warnings regarding dependency or addiction potential for this product.

Q: What other supplements or herbal products might interact with Folivit?

Official documentation specifically indicates that Folivit may reduce the efficacy of Zinc supplements. General caution is often noted, and regulatory information describes that healthcare providers may be informed of all other herbal remedies and supplements being used.

Q: Do people typically have to adjust other medications when starting Folivit?

The product's regulatory profile highlights documented interactions with specific medicines, such as certain anticonvulsants like Phenytoin. These interactions are noted to be two-way, meaning they may require clinical monitoring and potential adjustment of medication levels.

Q: Can Folivit lose its effectiveness over time?

The active ingredient, folic acid, is considered a stable form of the nutrient. Like all medicines, Folivit has a defined expiration date and must be stored according to regulatory instructions—such as protecting it from light and moisture in the original container—to ensure it maintains its effectiveness until that date.

Q: Does Folivit interact with hormonal birth control?

Clinical literature notes that women who use hormonal birth control may have impaired folate metabolism. This can be associated with slightly lower levels of folate in the serum and red blood cells, which is a known biological observation.

Q: Is the brand name Folivit more effective than the generic equivalent?

Regulatory standards require generic equivalents to contain the same medicinal ingredient as the brand name product. They must also meet bioequivalence standards, meaning they are proven to deliver the same amount of the active ingredient at the same rate and are therefore considered equally effective.

Q: Can Folivit affect the results of a routine blood test?

Yes, taking Folivit may interfere with the results of a blood test specifically intended to measure folate levels. Clinical guidelines sometimes describe stopping the supplement for a specified period before a folate level test is performed to prevent inaccurate readings.

Q: Why do official documents list so many potential side effects for Folivit?

Official regulatory documents are comprehensive and typically list all adverse events reported during clinical development and post-market surveillance. This means the list includes events that are very rare or have only been observed when significantly higher doses are taken.

Q: How does Folivit work differently than the drug that came before it?

Folivit (Folic Acid) is an essential vitamin, not a new chemical drug. Its regulatory profile emphasizes the crucial distinction from Vitamin B12, as Folic Acid can dangerously mask the signs of a B12 deficiency. Understanding this difference is key to safe use.

Q: Can Folivit be taken by people with liver issues?

Regulatory documentation lists specific populations that require conditional use or are contraindicated, primarily focusing on undiagnosed Vitamin B12 deficiency and severe renal (kidney) impairment. Liver issues are not explicitly listed as a contraindication or warning in the primary drug regulatory profile.

Q: Does Folivit have a warning about driving or operating machinery?

Official labeling may include a general statement that caution is advised due to the potential for side effects, even if rare. This caution is based on reports of central nervous system effects, such as difficulty concentrating or impaired judgment, particularly at higher doses.

Q: What is the general expectation for improvement when using Folivit?

For treating deficiency, authoritative sources describe that patients may generally see evidence of blood cell production returning to a normal state within several months of starting Folivit. This is associated with a reported improvement in deficiency-related symptoms like fatigue.

How should Folivit be stored and disposed of?

Folic Acid tablets, commonly branded as Folivit, must be stored within Controlled Room Temperature, typically 20 C to 25 C, with short excursions permitted up to 30 C.


Storage Conditions

The product must be protected from light and moisture and kept in the original, well-closed container. The container must utilize a child-resistant closure. For safety, the medicine must be stored out of the sight and reach of children.


Disposal Instructions

Unused or expired Folivit should not be discarded via wastewater or household trash. The official disposal methods include utilizing drug take-back programs at pharmacies or authorized collection sites. If no take-back program is available, the product must be mixed with an unappealing substance, sealed in a bag or container, and placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folivit found in:

A-Z Index: